p53 tumor suppressor gene: At the crossroads of molecular carcinogenesis, molecular epidemiology, and cancer risk assessment

Environmental Health Perspectives

Volumn 104, Issue SUPPL. 3, 1996, Pages 435-439

  Harris, Curtis C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer risk assessment; Molecular carcinogenesis; Molecular epidemiology; p53 gene

Indexed keywords

AFLATOXIN B1; CARCINOGEN;

BIOPSY; BODY FLUID; BREAST; CANCER; CANCER RISK; CARCINOGENESIS; COLON; CONFERENCE PAPER; ESOPHAGUS; GENE ACTIVATION; GENE FUNCTION; GENE MUTATION; GENETIC ANALYSIS; HEPATITIS B VIRUS; HUMAN; LIVER CANCER; LUNG; ONCOGENE; PRECANCER; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SKIN CANCER; SUNLIGHT; TUMOR SUPPRESSOR GENE;

EID: 0029976723     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.96104s3435     Document Type: Conference Paper

References (43)

1. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfez S, Ashkenazi M, Pecker I, Frydman M, Harnik R, Patanjali SR, Simmons A, Clines GA, Sartiel A, Gatti RA, Chessa L, Sanai O, Lavin MF, Jaspers NG, Malcolm A, Taylor R, Arlett CF, Miki T, Weissman SM, Lovett M, Collins FS, Shiloh Y. A single ataxia-telangiectasia gene with a product similar to PI-3 kinase. Science 268:1749-1753 (1995).
2. Harris CC, Hollstein M. Clinical implications of the p53 tumor-suppressor gene. N Engl J Med 329:1318-1327 (1993).
3. Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Liu S, Samid D, Duan DS, Gnarra JR, Linehan WM, Baylin SB. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA 91:9700-9704 (1994).
4. Bishop JM. Molecular themes in oncogenesis. Cell 64:235-248 (1991).
5. Harris CC. Chemical and physical carcinogenesis: advances and perspectives. Cancer Res 51:5023s-5044s (1991).
6. Weinberg RA. Tumor suppressor genes. Science 254:1138-1146 (1991).
7. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 253:49-53 (1991).
8. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855-4878 (1994).
9. Vogelstein B, Kinzler KW. p53 function and dysfunction. Cell 70:523-526 (1992).
10. Lane DP, Benchimol S. p53: oncogene or anti-oncogene. Genes Dev 4:1-8 (1990).
11. Dittmer D, Pati S, Zambetti G, Chu S, Teresky AK, Moore M, Finlay C, Levine AJ. Gain of function mutations in p53. Nature Genet 4:42-46 (1993).
12. Levine AJ, Momand J, Finlay CA. The p53 tumour suppressor gene. Nature 351:453-456 (1991).
13. Cho Y, Gorina S, Jeffrey P, Pavletich NP. Crystal structure of a p53 tumor suppressor-DNA complex: a framework for under-standing how mutations inactivate p53. Science 265:346-355 (1994).
14. Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, Baden HP, Halperin AJ, Ponten J. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Nad Acad Sci USA 88:10124-10128 (1991).
15. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 350:427-428 (1991).
16. Bressac B, Kew M, Wands J, Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 350:429-431 (1991).
17. Takeshima Y, Seyama T, Bennett WP, Akiyama M, Tokuoka S, Inai K, Mabuchi K, Land CE, Harris CC. p53 mutations in lung cancers from non-smoking atomic-bomb survivors. Lancet 342:1520-1521 (1993).
18. Bohr VA. Gene specific DNA repair. Carcinogenesis 12:1983-1992 (1991).
19. Chen RH, Maher VM, Brouwer J, van de Putte P, McCormick JJ. Preferential repair and strand-specific repair of benzo[a]pyrene diol epoxide adducts in the HPRT gene of diploid human fibroblasts. Proc Natl Acad Sci USA 89:5413-5417 (1992).
20. Evans MK, Taffe BG, Harris CC, Bohr VA. DNA strand bias in the repair of the p53 gene in normal human and xeroderma pigmentosum group C fibroblasts. Cancer Res 53:5377-5381 (1993).
21. Tornaletti S, Pfeifer GP. Slow repair of pyrimidine dimers at p53 mutation hotspots in skin cancer. Science 263:1436-1438 (1994).
22. Schaeffer L, Roy R, Humbert S, Moncollin V, Vermeulen W, Hoeijmakers JH, Chambon P, Egly JM. DNA repair helicase: a component of BTF2 (TFIIH) basic transcription factor. Science 260:58-63 (1993).
23. Selby CP, Sancar A. Molecular mechanism of transcriptionrepair coupling. Science 260:53-58 (1993).
24. Buratowski S. DNA repair and transcription: the helicase connection. Science 260:37-38 (1993).
25. Wang XW, Yeh H, Schaeffer L, Roy R, Moncollin V, Egly JM, Wang Z, Friedberg EC, Evans MK, Taffe BG, Bohr VA, Hoeijmakers JH, Forrester K, Harris CC. p53 Modulation of TFIIH-associated nucleotide excision repair activity. Nature Genet 10:188-195 (1995).
26. Aguilar F, Hussain SP, Cerutti P. Aflatoxin B1 induces the transversion of G→T in codon 249 of the p53 tumor suppressor gene in human hepatocytes. Proc Natl Acad Sci U S A 90:8586-8590 (1993).
27. Ponchel F, Puisieux A, Tabone E, Michot JP, Froschl G, Morel AP, Frebourg T, Fontaniere B, Oberhammer F, Ozturk M. Hepatocarcinoma-specific mutant p53-249ser induces mitotic activity but has no effect on transforming growth factor β 1-mediated apoptosis. Cancer Res 54:2064-2068 (1994).
28. Rideout WM III, Coetzee GA, Olumi AF, Jones PA. 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. Science 249:1288-1290 (1990).
29. Shen JC, Rideout WM III, Jones PA. High frequency mutagenesis by a DNA methyltransferase. Cell 71:1073-1080 (1992).
30. Nguyen T, Brunson D, Crespi CL, Penman BW, Wishnok JS, Tannenbaum SR. DNA damage and mutation In human cells exposed to nitric oxide in vitro. Proc Natl Acad Sci USA 89:3030-3034 (1992).
31. Wink DA, Kasprzak KS, Maragos CM, Elespuru RK, Misra M, Dunams TM, Cebula TA, Koch WH, Andrews AW, Allen JS, Keefer LK. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 254:1001-1003 (1991).
32. Knudson AG, Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:820-823 (1971).
33. Malkin D, Li FP, Strong LC, Fraumeni JF, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA, Friend SH. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250:1233-1238 (1990).
34. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA Jr, Butel JS, Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356:215-221 (1992).
35. Lavigueur A, Maltby V, Mock D, Rossant J, Pawson T, Bernstein A. High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene. Mol Cell Biol 9:3982-3991 (1989).
36. Hartwell L. Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell 71:543-546 (1992).
37. Livingstone LR, White A, Sprouse J, Livanos E, Jacks T, Tlsty TD. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70:923-935 (1992).
38. Yin Y, Tainsky MA, Bischoff FZ, Strong LC, Wahl GM. Wildtype p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70:937-948 (1992).
39. Kastan MB, Zhan Q, el-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B, Fornace AJ Jr. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71:587-597 (1992).
40. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362:849-852 (1993).
41. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362:847-849 (1993).
42. Barrett JC, Wiseman RW. Molecular carcinogenesis in humans and rodents. Prog Clin Biol Res 376:1-30 (1992).
43. National Research Council. Science and Judgement in Risk Assessment. Assessment of Toxicology (National Academy of Sciences, eds). Washington:National Academy Press, 1994;56-67.